Device Endotak Reliance_crm

Endotak Reliance S

Payments companies reported to CMS as associated with Endotak Reliance S. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$4,182associated payments (2023-2025)
121clinicians with associated payments
1company reporting

By year

2023 $1,452
2024 $1,189
2025 $1,542

Payments reported as associated with Endotak Reliance S, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Clinical Cardiac Electrophysiology $2,244
Cardiovascular Disease $408
Physician Assistant $238
Nurse Practitioner $214
Family $207
Adult Health (Nurse Practitioner) $186

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Endotak Reliance S

These are the largest totals companies reported as associated with Endotak Reliance S. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Shaun Bhatty Zanesville, OH Clinical Cardiac Electrophysiology $294.64
Thomas Callahan Cleveland, OH Clinical Cardiac Electrophysiology $194.38
Anna Robak New York, NY Physician Assistant $176.88
Ryan Cunnane Ann Arbor, MI Clinical Cardiac Electrophysiology $170.18
Paul Madaj Springfield, MA Clinical Cardiac Electrophysiology $169.84
Asad Mohammad New York, NY Clinical Cardiac Electrophysiology $156.21
Zaw Win Tun Hamilton, NJ Clinical Cardiac Electrophysiology $156.21
Sarita Rao Canton, MI Adult Health (Nurse Practitioner) $138.52
Sohail Hassan Dearborn, MI Cardiovascular Disease $138.52
Sharon Magoolaghan Stow, OH Nurse Practitioner $124.47

Prescribed Endotak Reliance S?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.